Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study
Authors:
- 30 March 2019
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 38 (5) , 1385-1391
Abstract
To investigate the cause-specific mortality and the possible involved clinical characteristics with increased mortality in a cohort of 700 patients with crystal-proven gout. The cause-specific mortality of gout was compared to the mortality of the general population.Keywords
This publication has 24 references indexed in Scilit:
- Contribution of uric acid to cancer risk, recurrence, and mortalityClinical and Translational Medicine, 2012
- Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008The American Journal of Medicine, 2012
- Increased risk of cancer among gout patients: A nationwide population studyJoint Bone Spine, 2012
- Gout and the risk for incident heart failure and systolic dysfunctionBMJ Open, 2012
- Elevated risk of mortality among gout patients: A comparison with the National Population in TaiwanJoint Bone Spine, 2011
- Hyperuricemia and coronary heart disease: A systematic review and meta‐analysisArthritis Care & Research, 2010
- Gout: an independent risk factor for all-cause and cardiovascular mortalityRheumatology, 2009
- Hyperuricemia and risk of stroke: A systematic review and meta‐analysisArthritis Care & Research, 2009
- Long-term Cardiovascular Mortality Among Middle-aged Men With GoutArchives of internal medicine (1960), 2008
- Prevalence of the metabolic syndrome in patients with gout: The Third National Health and Nutrition Examination SurveyArthritis Care & Research, 2007